Armata Pharmaceuticals, Inc. (ARMP)

Armata Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	19.24	20.81	11.49	10.85	6.73
Cash & Cash Equivalents	19.24	20.81	11.49	10.85	6.73
Cash Growth	-7.54%	81.16%	5.89%	61.13%	-35.65%
Receivables	3.36	8.53	0	0	0
Other Current Assets	-3.46	-2.3	3.51	-0	-0.08
Total Current Assets	19.15	27.05	15	10.85	6.66
Property, Plant & Equipment	57.28	46.65	38.07	12.84	4.22
Goodwill and Intangibles	3.49	3.49	3.49	3.49	3.49
Other Long-Term Assets	18.45	18.65	13.21	12.34	11.09
Total Long-Term Assets	79.21	68.79	54.77	28.67	18.8
Total Assets	98.36	95.83	69.77	39.52	25.45
Accounts Payable	5.69	6.03	2.27	1.93	1.28
Current Debt	9.48	17.01	1.51	2.27	1.31
Other Current Liabilities	1.29	1.83	1.04	2.5	2.29
Total Current Liabilities	16.46	24.87	4.81	6.71	4.88
Long-Term Debt	110.89	31.8	36.48	10.88	1.56
Other Long-Term Liabilities	3.08	3.08	3.08	3.08	4.42
Total Long-Term Liabilities	113.97	34.88	39.56	13.95	5.98
Total Liabilities	130.43	59.75	44.37	20.66	10.86
Total Debt	120.37	48.82	37.99	13.15	2.86
Debt Growth	146.59%	28.50%	188.89%	359.31%	-
Retained Earnings	-308.82	-239.77	-202.86	-179.7	-157.52
Shareholders' Equity	-32.07	36.08	25.4	18.86	14.59
Net Cash / Debt	-101.13	-28	-26.5	-2.3	3.87
Net Cash / Debt Growth	-	-	-	-	-63.01%
Net Cash Per Share	-2.80	-0.82	-1.10	-0.14	0.48
Working Capital	2.69	2.17	10.18	4.14	1.78
Book Value Per Share	-0.89	1.05	1.05	1.15	1.86

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).